Jesús Fortún

TL;DR: Treatment duration for aspergillosis is strongly recommended based on clinical improvement, degree of immunosuppression and response on imaging, and in refractory disease, where a personalized approach considering reversal of predisposing factors, switching drug class and surgical intervention is also strongly recommended.

TL;DR: HIV-infected individuals with COVID-19 should not be considered to be protected from SARS-CoV-2 infection or to have lower risk of severe disease, and they should receive the same treatment approach applied to the general population.

TL;DR: Risk factors in patients with early-onset cases and patients with late-onsets cases of posttransplantation invasive aspergillosis are not the same, a fact that could have implications for the preventive approaches used for this infection.

TL;DR: Tuberculosis incidence is increased among SOT recipients and the risk factors identified were age and receipt of a lung transplant and the highest incidence was observed among lung transplant recipients.

TL;DR: A series of recommendations regarding the types of drugs and the duration of treatment of tuberculosis in solid-organ recipients are established, giving special attention to pharmacological interactions between rifampin and immunosuppressive drugs.